ARCHIVES

“Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged”

This article is from The Cancer Letter archive.

Vol. 02 No. 04 | January 23, 1976

Download PDF Visit The Full Archive

Related Articles

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985

Cancer Policy: Board Advocates $2 Per Pack Raise For Cigarettes

January 16, 1998

Roswell Park Wins $2.8 Million Grant

July 31, 2009

Clearinghouse Delves Into Carcinogenesis Issues – Test Validity, Interpretation, In Vitro Methods

August 12, 1977

Amgen Commits $1.5M To CDC Foundation For Education Program

May 29, 2009

In Brief: NCI Encourages New Grants In For Cancer Sites In Forthcoming PA, Broder Informs Grantees

January 3, 1992